Ciprofloxacin for post-exposure prophylaxis of anthrax : emergency use instructions for healthcare providers
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Ciprofloxacin for post-exposure prophylaxis of anthrax : emergency use instructions for healthcare providers

Filetype[PDF-183.85 KB]


English

Details:

  • Alternative Title:
    Ciprofloxacin EUI for Healthcare Providers;Ciprofloxacin Emergncy Use Instructions for Healthcare Providers;
  • Corporate Authors:
  • Description:
    This fact sheet provides instructions for the use of ciprofloxacin for post‐exposure prophylaxis (PEP) during an emergency involving anthrax (referred to as Emergency Use Instructions (EUI) fact sheet). Ciprofloxacin is FDA‐approved for PEP of inhalation anthrax – to reduce the incidence or progression of disease following exposure to aerosolized Bacillus anthracis (B. anthracis). The Food and Drug Administration (FDA) has also issued an order permitting the emergency dispensing of oral formulations of ciprofloxacin without a prescription during an anthrax emergency to individuals who may have been exposed to B. anthracis.

    Ciprofloxacin EUI for Healthcare Providers (originally issued 03/28/2016; revised 08/18/2017)

    cipro-eui-hcp-H.pdf

  • Subjects:
  • Document Type:
  • Genre:
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

Supporting Files

  • No Additional Files
More +

Related Documents

You May Also Like

Checkout today's featured content at stacks.cdc.gov